Literature DB >> 9520112

Expression of type VI collagen in the developing mouse heart.

S E Klewer1, S L Krob, S J Kolker, G T Kitten.   

Abstract

During development, the embryonic atrioventricular (AV) endocardial cushions undergo a morphogenic process to form mature valve leaflets and the membranous septa in the heart. Several extracellular matrix (ECM) proteins are expressed in the developing AV endocardial cushions, but it remains to be established if any specific ECM proteins are necessary for normal cushion morphogenesis. Abnormal development of the cardiac AV valves is a frequent cause of congenital heart defects, particularly in infants with trisomy 21 (Down syndrome). The genes encoding the alpha1 and alpha2 chains of type VI collagen are located on human chromosome 21 within the region thought to be critical for congenital heart defects in trisomy 21 infants. This suggests that the type VI collagen alpha1(VI) and alpha2(VI) chains may be important in normal AV valve morphogenesis. As a first step in understanding the role of type VI collagen in valve development, the authors examined the normal spatial and temporal expression patterns of mRNA and protein for type VI collagen in the embryonic mouse heart. Ribonuclease protection assay analysis demonstrates cardiac expression of the type VI collagen for alpha1(VI), alpha2(VI), and alpha3(VI) transcripts beginning at embryonic days 11-11.5 of mouse development. In situ hybridization studies demonstrate a coordinated pattern of cardiac expression within the AV valves for each type VI collagen chain from embryonic day 11.5 through the neonatal period. Immunohistochemical studies confirm a concentrated type VI collagen localization pattern in the endocardial cushions from the earliest stages of valve development through the neonatal period. These data indicate that type VI collagen is expressed in the developing AV canal in a pattern consistent with cushion tissue mesenchymal cell migration and proliferation, and suggest that type VI collagen plays a role in the morphogenesis of the developing cardiac AV endocardial cushions into the valve leaflets and membranous septa of the heart.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520112     DOI: 10.1002/(SICI)1097-0177(199803)211:3<248::AID-AJA6>3.0.CO;2-H

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  23 in total

Review 1.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling.

Authors:  Joyce A Schroeder; Leslie F Jackson; David C Lee; Todd D Camenisch
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

2.  Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro.

Authors:  C Williams; K P Quinn; I Georgakoudi; L D Black
Journal:  Acta Biomater       Date:  2013-09-06       Impact factor: 8.947

Review 3.  Extracellular matrix and heart development.

Authors:  Marie Lockhart; Elaine Wirrig; Aimee Phelps; Andy Wessels
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-25

4.  Expression and deposition of fibrous extracellular matrix proteins in cardiac valves during chick development.

Authors:  Hong Tan; Lorain Junor; Robert L Price; Russell A Norris; Jay D Potts; Richard L Goodwin
Journal:  Microsc Microanal       Date:  2010-12-23       Impact factor: 4.127

5.  Regulation of cardiac cushion development by hyaluronan.

Authors:  T D Camenisch; J Biesterfeldt; T Brehm-Gibson; J Bradley; J A McDonald
Journal:  Exp Clin Cardiol       Date:  2001

Review 6.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

7.  Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance.

Authors:  Jacqueline D Peacock; Yinhui Lu; Manuel Koch; Karl E Kadler; Joy Lincoln
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

Review 8.  Heart valve development: regulatory networks in development and disease.

Authors:  Michelle D Combs; Katherine E Yutzey
Journal:  Circ Res       Date:  2009-08-28       Impact factor: 17.367

9.  Heart defects and ocular anomalies in children with Down's syndrome.

Authors:  N R Bromham; J M Woodhouse; M Cregg; E Webb; W I Fraser
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

10.  Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix.

Authors:  Frédéric Delom; Emma Burt; Alex Hoischen; Joris Veltman; Jürgen Groet; Finbarr E Cotter; Dean Nizetic
Journal:  Proteome Sci       Date:  2009-08-28       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.